An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic parkinson disease with dementia and without dementia

Alzheimer Disease and Associated Disorders

Volumn 27, Issue 1, 2013, Pages 51-55

  Song, In Uk ^a,b   Kim, Young Do ^a,b   Cho, Hyun Ji ^a,b   Chung, Sung Woo ^a,b   Chung, Yong An ^b,c  

^a Department of Biochemistry and Molecular Biology   (South Korea)

^b Bupyeong gu   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

dementia; dopamine transporters; FP CIT PET; idiopathic Parkinson disease

Indexed keywords

DOPAMINE TRANSPORTER;

ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; HUMAN; IDIOPATHIC PARKINSON DISEASE; MOTOR DYSFUNCTION; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN;

AGED; BRAIN; DEMENTIA; DOPAMINERGIC NEURONS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TROPANES;

EID: 84874273903     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31824acd84     Document Type: Article

References (22)

1. Rinne OJ, Nurmi E, Ruottinen HM, et al. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease. Synapse. 2001;40:193-200.
2. Eshuis SA, Maguire RP, Leenders KL, et al. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de nove and advanced Parkinson's disease. Eur J Neucl Med Mol Imaging. 2006;33:200-209.
3. Hughes AJ, Daniel SE, Ben Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861-870.
4. Wang J, Zuo CT, Jiang YP, et al. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages. J Neurol. 2006;185-190.
5. Kazumata K, Khawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998;39:1521-1530.
6. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol. 2003;2:229-237.
7. Rossi C, Volterrani D, Nicoletti V, et al. "Parkinsondementia" disease: a comprison by double tracer SPECT studies. Parkinsonism Relat Disord. 2009;15:762-766.
8. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:143-147.
10. Kang YW, Na DL, Hahn SH. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15:300-308.
11. Choi SH, Na DL, Lee BH, et al. Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale. J Korean Neurol Assoc. 2001;19:585-591.
12. Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathological study of 100 cases of Parkinson's disease. Arch Neurol. 1993;50:140-148.
13. Benamer HT, Patterson J, Wyper DJ, et al. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15:692-698.
14. Seibyl JP, Marek K, Sheff K, et al. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients J Nucl Med. 1998;39:1500-1508.
15. Kim JS. Practical approach for the clinical use of dompamine transporter imaging. Nucl Med Mol Imaging. 2008;42: 425-434.
16. Walker Z, Costa DC, Walker RW, et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology. 2004;62:1568-1572.
17. O'Brien JT, Colloby S, Fenwick J, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol. 2004;61:919-925.
18. McKeith I, O'Brien J, Walker Z, et al. DLB Study Group. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305-313.
19. Walker Z, Jaros E, Walker RW, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry. 2007;78:1176-1181.
20. Nurmi E, Bergman J, Eskola O, et al. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET. Synapse. 2003;48: 109-115.
21. Ravina B, Eidelberg D, Ahiskog JE. The role of radiotracer imaging in Parkinson disease. Neurology. 2005;64:208-215.
22. Ma Y, Dhawan V, Mentis M, et al. Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease; a PET study. Synapse. 2002;45:125-133.